Wacker Chemie AG Financial Results H1 2026 | Results & Outlook
Investor Snapshot
- COMPANY
- Wacker Chemie AG
- FORMAT
- Financial Results
- SPEAKER
- Jörg Hoffmann
- ROLE
- Head of Investor Relations
- DURATION
- 12:20
- PUBLISHED
- July 2026
- LANGUAGE
- English
In 60 Seconds
In this financial results presentation on seat11a, Jörg Hoffmann, Head of Investor Relations at WACKER Chemie AG, presents the company's First Half 2026 Financial Results and discusses financial performance, business segment developments, operational improvements, and the updated outlook for the year.
July 30, 2026
12:20 
Wacker Chemie AG H1 2026: Key Takeaways
WACKER Chemie AG First Half 2026 Financial Results Presentation
In this financial results presentation on seat11a, Jörg Hoffmann, Head of Investor Relations at WACKER Chemie AG, presents the company’s First Half 2026 Financial Results and discusses financial performance, business segment developments, operational improvements, and the updated outlook for the year.
First Half 2026 Financial Performance
During the second quarter of 2026, WACKER increased sales by 7% year-on-year to €1.52 billion. Reported EBITDA rose to €211 million, while EBITDA before special effects reached €175 million, supported by higher volumes, improved pricing, and continued savings from the company’s PACE efficiency program. Net income increased significantly to €350 million, primarily reflecting Siltronic-related valuation and transaction effects.
Chemicals, Biosolutions and Polysilicon Business Developments
The Chemicals division delivered strong operational performance across both Silicones and Polymers. Higher volumes, price increases to offset raw material inflation, and operational improvements supported higher profitability, while Biosolutions continued to benefit from BioPharma project business and disciplined cost management. The Polysilicon business continued to benefit from strong semiconductor demand, although solar markets remained challenging due to weak pricing, Chinese overcapacity, and regulatory uncertainty in the United States.
PACE Efficiency Program Driving Operational Improvements
A major focus of the presentation is the company’s PACE efficiency program, which continues to improve operational performance across the Group. Management highlighted approximately €45 million of savings achieved during the quarter and reaffirmed the long-term target of generating more than €300 million in cumulative annual savings by 2028.
Strong Balance Sheet and Updated FY 2026 Outlook
The presentation also highlights WACKER’s strong financial position. Liquidity remained high at €1.57 billion, shareholder equity increased to €4.18 billion, and net financial debt declined to €722 million. Following the stronger first-half performance, management raised its FY 2026 EBITDA guidance to €625–750 million while maintaining expectations for mid-single-digit sales growth during the year.
- WACKER Q2 2026 Highlights
- FY 2026 Outlook UpdatedReported EBITDA In The Range From €625 to 750m
- Q2 2026 EBITDA At €211m Includes Effect From Pensions, EBITDA Before Specials at €175m Supported By PACE And Volume
- Financials With €1.57bn In Liquidity And €4.18bn In Equity
- Silicones: EBITDA Higher On PACE & Positive Mix Effects
- Polymers: EBITDA Higher On PACE And Inventory Effects
- Biosolutions: Sales And EBITDA Improvement YoY
- Polysilicon: Strong Semi Demand, Uncertainty In Solar Continues
- Net Debt At €722m, Siltronic Effect Of +€185m Included In Cash Flow From Investing
- Appendix Q2/26 Special Effects
- WACKER: Issuer, Contact and Additional Information
This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/
Continuing the Journey: More Presentations
Discover Additional Elevator Pitches
(c) seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG
Unlock the insights of top publicly listed companies with seat11a.com